吉林无痛包皮手术到底要多少钱吉林包皮有什么影响,吉林性兴奋后睾丸疼痛怎么治疗,吉林治疗包皮炎哪家医院比较好,吉林男科医院 网上挂号,吉林阳痿早泄什么方法可以治好,吉林治疗性功能障碍的男子医院,吉林最好的治疗男科医院在哪里

The Southeast's first winter storm of the season has faded, with clear conditions expected Tuesday, but tens of thousands of people remain without power after the weekend's record-setting snow.The storm killed three people in North Carolina and grounded thousands of flights in the region, including more than 500 flights on Monday.Early Tuesday, more than 44,500 customers in North Carolina, 20,000 in South Carolina and 15,600 in Virginia were without power, according to Poweroutage.US.PHOTOS: As southeastern winter storm fades, canceled flights and icy roads remainCNN meteorologist Michael Guy said temperatures Tuesday would be cold, but above freezing. "At night there will still be possibilities of refreezing over bridges and overpasses on the roads," he warned.The Virginia Department of Transportation advised drivers to allow extra braking distance and to take it slow."If you plan to travel overnight, watch for slick roads & use extra caution. Dropping temps could cause any moisture on the roadways to refreeze," the transportation department said on Twitter.North Carolina Emergency Management also warned on Twitter that freezing nighttime temperatures could make driving hazardous. Black ice is possible Wednesday morning, it said. 1262

The two children who were rescued from an RV after an hours-long chase ended in Kern County, California have been reunited with their mother. The Los Angeles County Sheriff's Office posted pictures on Twitter at about 2 a.m. Wednesday, showing the children with their mom at an office. LACSO says both children were unharmed following Tuesday's pursuit.  377

The U.S. continues to lead the world in deaths linked to COVID-19 with more than 222,000 — and some experts believe that figure is much higher. But according to a new study, at least 130,000 of those deaths could have been avoided.According to a study by the National Center for Disaster Preparedness at Columbia University, the U.S. could have avoided between 130,000 and 210,000 COVID-19 deaths had the country adopted mitigation policies similar to those used by other "high-income nations."It's clear that the U.S. has disproportionately felt the affects of the pandemic — though it has just 4% of the world's population, it accounts for 20% of COVID-19 cases worldwide. The U.S. death toll stands in stark contrast to countries with similar resources, like South Korea, Japan, Australia, Germany, Canada, and France.To calculate the U.S.'s "avoidable deaths," the study applied the death rates of those countries to the U.S.'s population. Researchers then subtracted that figure from the U.S.'s current death count.By that calculation, researchers concluded that 130,000 lives could have been saved had the U.S. adopted policies similar to that of Canada's, and that as many as 215,000 lives could have been saved had the country adopted policies similar to South Korea.In explaining why U.S. deaths are disproportionately high, the Columbia researchers cited four key mistakes:Insufficient testing capacity: Researchers cited issues the U.S. had early on in the pandemic in developing and acquiring tests, while countries like South Korea were prepared almost immediately to test for the virus on a widespread scale.Delayed response: A previous Columbia University study determined that instituting national social distancing measures just one or two weeks earlier would have saved 36,000 of lives.Lack of a national mask mandate: Top health officials recommended against masks early on in the pandemic, fearing that doing so would lead to a shortage. Even today, masks have become politicized in some circles despite evidence showing that wearing one reduces the spread of droplets that can carry the virus.Failure from federal leadership: The Columbia study cited the Trump administration's "hostility to much of the critical guidance and recommendations put forth by its own health agencies," specifically citing the president's attempts to "downplay" the virus.Read more about the Columbia University study here. 2430

The US Food and Drug Administration expanded?the list of drugs being recalled that contain valsartan. The drug is used as a component in a set of drugs used to treat heart failure and blood pressure.New to the list are some valsartan products manufactured by Hetero Labs Ltd. in India, which are labeled as Camber Pharmaceuticals Inc. Test results show that some of the products may be tainted.The FDA announced a valsartan recall in July after lab tests revealed that some drugs could have been tainted with a substance linked to higher risk of cancer. The drug had been recalled in 22 other countries. The expanded recall includes some drugs that contain valsartan and hydrochlorothisazide. Not all of the drugs containing valsartan were affected.N-nitrosodimethylamine or NDMA, the impurity the lab tests found, is considered a?possible carcinogen by the US Environmental Protection Agency. It is an organic chemical that has been used to make liquid rocket fuel, and it can be unintentionally introduced through certain chemical reactions. It's a byproduct of the manufacturing of some pesticides and fish processing.The medicines that are now a part of this expanded list?in the recall are tablets sold by AvKare, A-S Medication Solutions LLC, Bryant Ranch Prepack Inc, Camber Pharmaceuticals, Inc. H J Harkins Company, Northwind Pharmaceuticals, NuCare Pharmaceuticals Inc., Prinston Pharmaceutical Inc. (labeled as Solco Healthcare LLC), Proficient Rx LP, Remedy Repack, Teva Pharmaceuticals (labeled as Major Pharmaceuticals), Teva Pharmaceuticals USA (labeled as Actavis).The FDA also published a list of valsartan products that are not currently recalled. Only the drugs suspected of being tainted with NDMA are on the recall list. If you are taking a valsartan drug, look for the company name on your prescription bottle. If the information isn't on the label, you can call your pharmacy for those details.The recalled medicine is linked to a manufacturer in China. The substances were supplied by Zhejiang Huahai Pharmaceuticals, based in Linhai, in eastern China, which said it notified authorities as soon as it identified the impurity."We published our recall notice at midday on July 13 in China and overseas, and published the US market recall notice on July 14 Beijing time ... all the drug materials for the Chinese market were recalled by July 23," the company said in a statement to the Shanghai stock exchange last month.The FDA said on its website that it's working with drug manufacturers "to ensure future valsartan active pharmaceutical ingredients are not at risk."If you are worried that your drug could be on the recall list, talk with your doctor or pharmacist before changing any routine with your medicine. Because not all valsartan drugs are involved in the recall, they might be able to switch you to a version of the drug made by another company.If you know your drug is on the recall list, the FDA suggests you continue taking it until your doctor or pharmacist provides a replacement.To get a sense of what taking a tainted drug could mean, FDA scientists estimated that if 8,000 people took the highest dose of valsartan (320 milligrams) from the recalled batches every day for four years, there may be one additional case of cancer."The key with this is, patients should not stop taking their medication abruptly, that definitely can be harmful," Dr. Mary Ann Bauman, a representative for the American Heart Association, said in July. "You don't want to jump to any conclusions on your own about this medication, or any medication for that matter. Definitely talk with your doctor first." 3690

The World Health Organization is preparing for the "worst case scenario" as it continues to respond to the Ebola outbreak in the Democratic Republic of Congo.Peter Salama, deputy director-general of emergency preparedness and response at the WHO, said in Geneva, Switzerland, on Friday that it's "going to be tough and it's going to be costly to stamp out this outbreak."As of Wednesday, 32 people are suspected to have been infected with Ebola viral disease, including three health care workers. Eighteen of those have died, including one of the health care workers.Of the suspected cases, two have been confirmed as Ebola using laboratory tests, and 10 samples are awaiting results."The number of suspected, probable and confirmed cases is significant, so we are very concerned, and we are planning for all scenarios, including the worst-case scenario," Salama said.Ebola virus disease, which most commonly affects people and nonhuman primates such as monkeys, gorillas and chimpanzees, is caused by one of five Ebola viruses. On average, about 50% of people who become ill with Ebola die.The disease is endemic to the Democratic Republic of Congo, and this is the nation's ninth outbreak since the discovery of the virus in the country in 1976.The latest outbreak is occurring in the Bikoro health zone, 400 kilometers (about 250 miles) from Mbandaka, the capital of Equateur province.Bikoro health zone has a population of about 163,000, with three hospitals and 19 health centers, most with limited functionality, according to WHO.Given the remote location of the outbreak, Salama said, response efforts will be extremely challenging. "It is a dire scene in terms of infrastructure," he said."To give you a sense, we are talking about an area that is 280 kilometers even from the provincial capital of Equateur," he said.The WHO is working with authorities in Congo and is in discussions with the World Food Programme to arrange airlifting supplies to the affected areas. UNICEF is also making doctors available as well as sanitation and hygiene specialists to help contain the outbreak.The virus is transmitted to people from wild animals and spreads in the human population through human-to-human transmission, either through direct contact with bodily fluids such as blood or secretions or contact with materials that are contaminated with these liquids.Personal protective equipment has been sent to the affected region, and the WHO is planning to have mobile laboratories running by the weekend, after receiving approval from the country's Ministry of Health.Initial control efforts are focusing on tools such as surveillance and monitoring, safe burials and case management.Vaccines along with doctors and epidemiologists are on standby in case they are needed, according to the UN.If they are needed, "WHO is in discussions with the government and, if pertinent, will seek approval from the national regulatory authority and the Ethics Review committee to use vaccines against Ebola as part of the response," spokesman Tarik Jasarevik said.The current vaccine against Ebola is experimental and not a licensed product. Salama pointed out that its use also comes with many challenges, as the vaccine needs to be stored long-term at temperatures between minus 60 to minus 80 degrees Celsius (minus 76 to minus 112 Fahrenheit)."This is not a simple logistical effort; it's not like doing a polio campaign with oral polio vaccines, where we get it immediately out to the field. This is a highly complex sophisticated operation in one of the most difficult terrains on Earth," Salama said.Nine neighboring countries are on high alert, Salama said, but the WHO says the current risk of disease spreading to them is low.West Africa experienced the largest recorded outbreak of Ebola over a two-year period beginning in March 2014; a total of 28,616 confirmed, probable and suspected cases were reported in Guinea, Liberia and Sierra Leone, with 11,310 deaths, according to the WHO.  3999